NightstaRx Ltd, a biopharmaceutical company specialising in developing gene therapies for inherited retinal dystrophies, announces a $35 million Series B financing round. The round was led by New Enterprise Associates, one of the world’s leading ventur…
Uncategorized
Research and Markets: Keratoconjunctivitis sicca (Dry Eye) – Pipeline Review, H2 2015
DUBLIN–(BUSINESS WIRE)–Research and Markets (http://www.researchandmarkets.com/research/9jsxk2/keratoconjunctivit) has announced the addition of the “Keratoconjunctivitis sicca (Dry Eye) – Pipeline Review, H2 2015” report to their offering. This repo…
Uncategorized
Eleven Biotherapeutics posts $9.7 million net loss in third quarter
Eleven Biotherapeutics reported a net loss of $9.7 million, or $0.50 per share, in the third quarter compared with a net loss of $10.7 million, or $0.66 per share, in the same quarter of 2014, according to a press release. Revenue was reported at $0.1 …
Research and Markets: Global Ophthalmology Devices – Industry Analysis 2015-2019 – Growing attention toward subtypes of eye diseases
DUBLIN–(BUSINESS WIRE)–Research and Markets (http://www.researchandmarkets.com/research/n7kfbw/global) has announced the addition of the “Global Ophthalmology Devices – Industry Analysis 2015-2019” report to their offering. The global ophthalmology d…
Uncategorized
VIDEO: Kamra inlay shows promise in presbyopia patients
NEW YORK — At OSN New York 2015, Parag A. Majmudar, MD, discusses the early U.S. experience with the AcuFocus’ Kamra inlay. The Kamra inlay does show some promise in allowing us to improve patients’ near vision while maintaining distance vision with minimal loss of quality.
Glaukos Technologies Featured in Podium and Poster Presentations at 2015 American Academy of Ophthalmology
LAS VEGAS–(BUSINESS WIRE)–Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures designed to transform the treatment of glaucoma, announced today that its products will be featured in several presentations and courses at the annual American Academy of Ophthalmology (AAO) meeting being held in Las Vegas, Nevada on November 14 – 17, 2015. In addition, Glaukos will host a major symposium